发明名称 Iterative Discovery Of Neoepitopes And Adaptive Immunotherapy And Methods Therefor
摘要 Contemplated cancer treatments comprise recursive analysis of patient-, cancer-, and location-specific neoepitopes from various biopsy sites of a patient after treatment or between successive rounds of immunotherapy and/or chemotherapy to inform further immunotherapy. Recursive analysis preferably includes various neoepitope attributes to so identify treatment relevant neoepitopes.
申请公布号 US2017028043(A1) 申请公布日期 2017.02.02
申请号 US201615291911 申请日期 2016.10.12
申请人 NantOmics, LLC 发明人 Benz Stephen Charles;Niazi Kayvan;Soon-Shiong Patrick;Nguyen Andrew
分类号 A61K39/00;G06F19/20;G06F19/00;C07K16/00 主分类号 A61K39/00
代理机构 代理人
主权项 1. A method of guided immunotherapy for a patient diagnosed with a tumor, comprising: receiving omics data for tumor cells in a first location in a patient, and receiving omics data for tumor cells in a second location in a patient; using the omics data to determine respective neoepitopes in the tumor cells of the first and second locations; identifying treatment relevant neoepitopes in the tumor cells of the first and second locations using at least one of a group attribute, a location attribute, a function attribute, a metabolic attribute, and a pathway attribute; and creating an immunotherapeutic composition using the treatment relevant neoepitopes, and administering the immunotherapeutic composition to the patient.
地址 Culver City CA US